vTv Therapeutics (VTVT) Total Current Liabilities (2014 - 2026)

vTv Therapeutics has disclosed Total Current Liabilities across 13 years of filings, most recently posting $7.0 million for Q2 2026.

• In Q2 2026, Total Current Liabilities rose 32.52% year-over-year to $7.0 million; the TTM figure through Jun 2026 stood at $7.0 million (up 32.52% YoY), while the FY2025 annual figure was $6.6 million, up 27.81% from the prior year.
• Total Current Liabilities came in at $7.0 million for Q2 2026 at vTv Therapeutics, up from $6.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $12.7 million in Q1 2022 to a low of $4.3 million in Q1 2025.
• Average Total Current Liabilities over 5 years is $8.0 million, with a median of $7.6 million recorded in 2022.
• Year-over-year, Total Current Liabilities jumped 146.03% in 2022 and slumped 51.62% in 2025.
• Over 5 years, Total Current Liabilities stood at $7.7 million in 2022, then jumped by 37.77% to $10.6 million in 2023, then slumped by 51.07% to $5.2 million in 2024, then gained by 27.81% to $6.6 million in 2025, then climbed by 5.66% to $7.0 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $7.0 million in Q2 2026, $6.9 million in Q1 2026, and $6.6 million in Q4 2025.